semaglutide
We Compare Obesity Treatment Costs: Tirzepatide Undercuts Semaglutide
A recent analysis shows tirzepatide can lower a patient’s annual out-of-pocket expense by $1,400 compared with semaglutide, meaning the newer GLP-1 drug often undercuts its predecessor on total cost. This shift matters most for people juggling insurance gaps and rising drug prices. Medical Disclaimer: This article is for